olaparib,breastcancer

Mashup Score: 1

OlympiA Study Demonstrates the Efficacy of Olaparib in the Treatment of Early Breast Cancer | Docwire News - 24 day(s) ago

Aliya Omer, AstraZeneca, talks about data that backs the efficacy of olaparib in treating high-risk early breast cancer.

Source: www.docwirenews.com

Categories: General Medicine News, Partners & KOLs

Tweet Tweets with this article
- mydocwire
  
  📰 Aliya Omer, @AstraZeneca, recently spoke to DocWire News about data that back the efficacy of #olaparib in treating high-risk early #breastcancer. 📺 Watch Now: https://t.co/yDBtgGER8s https://t.co/etQwZPay6l